CNOverview
iGeneTech, independently developed BisCap® methylation capture sequencing technology, is pleased to introduce the BisCap® CpG Galaxy Panel. This advanced pre-defined methylation capture probe product covers 100.7 Mb genomic region. It includes 98% of the CpG sites of the Illumina 935K chip. Moreover, the panel is enhanced with 12 methylation markers specifically designed for the multiple cancer early detection (MCED) of eight major cancer types: gastric, pancreatic, prostate, colorectal, lung, liver, esophageal, and ovarian cancer.
